Research output per year
Research output per year
Personal profile
Other research
PhD funded by the NIHR Manchester Biomedical Research Centre
Biography
Areas of research interest:
- Clinical disease outcome measures in inflammatory arthritis.
- Analysis of large-scale, multi-faceted molecular data.
- Early-phase clinical trials, with particular reference to dosing alteration that has been informed by population pharmacokinetic modelling and simulation.
My research is informed by the daily, lived experiences of patients with a diagnosis of a rheumatic disease. My background as a clinician means that I have a unique perspective when interpreting complex epidemiological and biological data, and improving outcomes for patients is at the heart of every research question.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, Personalising dosing of biologic therapies in inflammatory arthritis to maximise cost-benefit, The University of Manchester
Award Date: 7 Apr 2022
Bachelor of Medicine and Bachelor of Surgery
Sept 2005 → Jul 2011
Master of Research, Clinical Sciences
Jul 2009 → Jul 2010
Fingerprint
Dive into the research topics where Stephanie Ling is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis
Ling, S. F., Ho, P., Bukhari, M., Mewar, D., Chinoy, H., Morgan, A. W., Isaacs, J. D., Wilson, A. G., Hyrich, K. L., Barton, A. & Plant, D., 21 May 2025, (E-pub ahead of print) In: Scandinavian Journal of Rheumatology. p. 1-6 6 p.Research output: Contribution to journal › Article › peer-review
-
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis
Ling, S. F., Yap, C. F., Nair, N., Verstappen, S. M. M., Morgan, A. W., Isaacs, J. D., Wilson, A. G., Hyrich, K. L., Barton, A. & Plant, D., 13 May 2025, In: Rheumatology.Research output: Contribution to journal › Article › peer-review
-
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
Ling, S. F., Ogungbenro, K., Darwich, A. S., Ariff, A. B. M., Nair, N., Bluett, J., Morgan, A. W., Isaacs, J. D., Wilson, A. G., Hyrich, K. L., Barton, A. & Plant, D., 23 May 2024, In: Pharmaceutics. 16, 6, 702.Research output: Contribution to journal › Article › peer-review
Open Access -
RMD: Genetics for Rheumatologists
Ling, S. & Orozco, G., 2024, EULAR Publishers.Research output: Other contribution
-
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures
Ling, S., Yap, C. F., Nair, N., Bluett, J., Morgan, A. W., Isaacs, J. D., Wilson, A. G., Hyrich, K., Barton, A. & Plant, D., 30 Jun 2023, In: Rheumatology.Research output: Contribution to journal › Article › peer-review
Open AccessFile19 Downloads (Pure)
-
British Society for Rheumatology (External organisation)
Ling, S. (Academic expert member)
2024 → …Activity: Membership › Membership of committee › Research
-
EMEUNET (External organisation)
Ling, S. (Academic expert member)
2023 → …Activity: Membership › Membership of professional association › Teaching and Research
-
British Society of Rheumatology (External organisation)
Ling, S. (Member)
2022Activity: Membership › Membership of professional association › Research
Press/Media
-
-
People with arthritis take part in pioneering research that improves quality of life for future generations
1/09/21
1 Media contribution
Press/Media: Other
Thesis
-
Personalising dosing of biologic therapies in inflammatory arthritis to maximise cost-benefit
Ling, S. (Author), Barton, A. (Supervisor), Plant, D. (Supervisor), Ogungbenro, K. (Supervisor) & Bluett, J. (Supervisor), 1 Aug 2022Student thesis: Phd
File